ARTICLE | Clinical News
Simbrinza brinzolamide/brimonidine tartrate regulatory update
June 9, 2014 7:00 AM UTC
EMA's CHMP recommended approval of an MAA from Novartis' Alcon Inc. ophthalmic unit for Simbrinza brinzolamide/brimonidine tartrate to reduce intraocular pressure (IOP) in patients with primary open-...